Participants of project MODICELL will actively cooperate to cover clinical entities including cancer and transplantation, in which immune cell therapies are considered. 

The main scientific objectives within MODICELL are: 

  • The identification of factors critical to the generation of robust effector immune system responses, to eradicate cancer cells; or tolerogenic immune system responses, to improve tolerance towards transplanted organs.  
  • The generation of computer-based predictive models to aid in the identification of specific factors and/or pathways critical for induction of the desired types of immune responses.

Project Title: MODICELL

Project No.: 285875

Coordinator: Andreas Heitger

Start: 01/01/2013

Duration: 48 months


CORDIS: Project Details


The Project recieves funding from the European Union FP7-People Programme under grant agreement n° 285875

© MODICELL 2013, Webdesign by BIOLUTION